Back to team page

Patience Kurtz

Senior UX Researcher

Patience draws from her background in human-centered design, research, and art to help clients design and deliver meaningful experiences for users. Having worked in the hospitality industry for more than ten years, she loves learning from and connecting with people. Patience is passionate about applying UX research methods to promote accessibility and inclusive design practices. She has a Master’s degree in Digital Communication and Media Arts with an emphasis in human-computer interaction from DePaul University.

Bold facts

Learn more about

Patience

Something unique about you summed up in one sentence

I have always hated peanut butter…it’s something I’m working on.

Your favorite part of working at Bold Insight

Everyone is incredibly kind, supportive, and fun to work with.

In your spare time (or if you had spare time), you would absolutely do this:

I love reading and making things, but you’ll most likely find me searching for a good hiking spot outside of the city.

Your favorite city in the world is...and why?

I’m always looking for my next favorite! I’m happy anywhere that is easily walkable and has good food.

You cannot start the day without doing this:

Eating breakfast and listening to the Daily.

Your ultimate celebrity dinner party guest list would include:

Dan Levy, Catherine O’Hara, Anthony Bourdain, and Lizzo.

Long-term personal or professional goal?

I want to continue to contribute to work that makes life more enjoyable for as many people as possible. I also hope to accomplish something physically challenging. I’m not sure what that will be yet, but I can promise you it won’t be running a marathon!

Any other facts to share?

My background is in photography and the only reason I hope to own a house someday is so that I can build my own darkroom.
Read Patience's bold insights

Read our team’s latest bold insights

Human factors testing for OTC drugs and non-prescription medical devices

As the field of human factors continues to evolve, so must our approaches to testing and study design. While the FDA’s 2013 guidance laid the groundwork for study design and methodology, recent discussions and conference presentations have prompted a shift in how we approach OTC HF testing, leading to more comprehensive and realistic assessments of these products.

read more